WO2007056996A3 - Hypertension agent containing tribomechanically activated zeolites - Google Patents

Hypertension agent containing tribomechanically activated zeolites Download PDF

Info

Publication number
WO2007056996A3
WO2007056996A3 PCT/DE2006/002018 DE2006002018W WO2007056996A3 WO 2007056996 A3 WO2007056996 A3 WO 2007056996A3 DE 2006002018 W DE2006002018 W DE 2006002018W WO 2007056996 A3 WO2007056996 A3 WO 2007056996A3
Authority
WO
WIPO (PCT)
Prior art keywords
percent
weight
agent containing
hypertension agent
activated zeolites
Prior art date
Application number
PCT/DE2006/002018
Other languages
German (de)
French (fr)
Other versions
WO2007056996A2 (en
Inventor
Tihomir Lelas
Original Assignee
Ljubicic Mijo
Ivkovic Slavko
Tihomir Lelas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06090025A external-priority patent/EP1839666A1/en
Application filed by Ljubicic Mijo, Ivkovic Slavko, Tihomir Lelas filed Critical Ljubicic Mijo
Publication of WO2007056996A2 publication Critical patent/WO2007056996A2/en
Publication of WO2007056996A3 publication Critical patent/WO2007056996A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to pharmaceutical agents comprising 50 to 90 percent by weight of TMAZ, 1 to 30 percent by weight of ramson herb, 1 to 10 percent by weight of mistletoe herb, 1 to 10 percent by weight of silver linden blossoms, 1 to 10 percent by weight of hawthorn blossoms, and 1 to 10 percent by weight of ginkgo leaves. Also disclosed is the use of the pharmaceutical agent for treating diseases associated with hypertension.
PCT/DE2006/002018 2005-11-15 2006-11-14 Hypertension agent containing tribomechanically activated zeolites WO2007056996A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102005055328 2005-11-15
DE102005055328.1 2005-11-15
EP06090025.5 2006-02-15
EP06090025A EP1839666A1 (en) 2006-02-15 2006-02-15 Composition for treating hypertension comprising tribomechanically activated zeolites

Publications (2)

Publication Number Publication Date
WO2007056996A2 WO2007056996A2 (en) 2007-05-24
WO2007056996A3 true WO2007056996A3 (en) 2007-10-11

Family

ID=38048991

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2006/002018 WO2007056996A2 (en) 2005-11-15 2006-11-14 Hypertension agent containing tribomechanically activated zeolites

Country Status (1)

Country Link
WO (1) WO2007056996A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108355073A (en) * 2018-03-30 2018-08-03 甘肃大整健康管理股份有限公司 A kind of traditional Chinese medicine health care preparation for the lipoid and reducing blood pressure that disappears

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19755921A1 (en) * 1997-12-16 1999-06-17 Utp Dr Snyckers Gmbh Method and device for improving the effectiveness of active substances which consist at least of minerals
WO2000064586A1 (en) * 1999-04-26 2000-11-02 Tihomir Lelas Device for micronizing materials

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19755921A1 (en) * 1997-12-16 1999-06-17 Utp Dr Snyckers Gmbh Method and device for improving the effectiveness of active substances which consist at least of minerals
WO2000064586A1 (en) * 1999-04-26 2000-11-02 Tihomir Lelas Device for micronizing materials

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYM, INTERNET ARTIKEL, 2 March 2005 (2005-03-02), XP002387266, Retrieved from the Internet <URL:http://web.archive.org/web/20050302205630/http://vetera.de/vi-album.htm> [retrieved on 20060623] *
ANONYM, INTERNET ARTIKEL, 6 March 2005 (2005-03-06), XP002387265, Retrieved from the Internet <URL:http://web.archive.org/web/20050306014738/http://www.megamin.net/german/when.htm> [retrieved on 20060623] *
PREUSS H G ET AL: "Wild garlic has a greater effect than regular garlic on blood pressure and blood chemistries of rats.", INTERNATIONAL UROLOGY AND NEPHROLOGY. 2001, vol. 32, no. 4, 2001, pages 525 - 530, XP002387295, ISSN: 0301-1623 *
STEINMETZ E F, MATERIA MEDICA VEGETALIS, 1954, XP002387267, Retrieved from the Internet <URL:http://web.archive.org/web/20040104060621/http://www.heilpflanzen-suchmaschine.de/baerlauch/baerlauch_anwendung.shtml> [retrieved on 20060623] *
VOGEL J H K ET AL: "Integrating Complementary Medicine Into Cardiovascular Medicine", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, XX, XX, vol. 46, no. 1, 5 July 2005 (2005-07-05), pages 184 - 221, XP004962962, ISSN: 0735-1097 *
WINTHER KAJ ET AL: "Effects of Gingko biloba extract on cognitive function and blood pressure in elderly subjects", CURRENT THERAPEUTIC RESEARCH, vol. 59, no. 12, December 1998 (1998-12-01), pages 881 - 888, XP002387268, ISSN: 0011-393X *

Also Published As

Publication number Publication date
WO2007056996A2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
IL245489A0 (en) 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
EP1900362A3 (en) Alfa-aminoamide derivatives useful in the treatment of addictive disorders
EP2559694A3 (en) Azaindoles useful as inhibitors of Janus kinases
WO2007041130A3 (en) Deazapurines useful as inhibitors of janus kinases
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
WO2004074232A8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2004071382A3 (en) Substituted heterocycles
WO2008076392A3 (en) Compounds useful as protein kinase inhibitors
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2005007142A3 (en) Liquid compositions comprising formoterol
WO2006116148A3 (en) (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment&#39; of substance abuse
WO2008116139A3 (en) N-heterocyclic compounds useful as inhibitors of janus kinases
WO2007092496A3 (en) 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
WO2004080373A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
WO2007056996A3 (en) Hypertension agent containing tribomechanically activated zeolites
WO2005082884A3 (en) 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease
WO2007048034A3 (en) Use of androgens for the treatment of parkinson&#39; s disease
WO2005121074A3 (en) Processes for the preparation of sertraline hydrochloride
WO2003065044A3 (en) Diagnostics and therapeutics for diseases associated with gpr72
WO2006090265A3 (en) Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions
WO2005093091A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase

Ref document number: 06828523

Country of ref document: EP

Kind code of ref document: A2